G-18, SnehKunj Colony, Vyara, Dist. Surat, Gujarat – 394650
Shop No. 05, Aditya Shagun Mall, Bavdhan, Pune, Maharashtra – 411021
calygenpharma2017@gmail.com
Calohie-CG™ Injection
Calohie-CG Injection (Ceftriaxone 1000 mg + Disodium Edetate 37 mg + Sulbactam 500 mg) is a powerful, carbapenem-sparing combination of Ceftriaxone, Sulbactam, and Disodium Edetate (EDTA), specially formulated to tackle multi-drug resistant infections, particularly prevalent post-COVID.
Manufacturer Information
Marketed by: Calygen Pharma
Manufactured by: Proteck Telesis
(W.H.O-GMP Certified Plant, Sirmaur, H.P., India)
Description
Product Description:
Calohie-CG Injection is a synergistic triple combination of:
- Ceftriaxone (1000 mg)
- Disodium Edetate (37 mg)
- Sulbactam (500 mg)
This potent formulation increases antibiotic permeability and activity, providing an effective alternative in carbapenem-sparing strategies and enhancing outcomes in post-COVID resistant infections.
Key Benefits
- Synergistic action improves Ceftriaxone efficacy
- EDTA boosts permeability through bacterial membranes
- Highly effective (95%) against ESBL and MBL strains (vs. 89% for Colistin)
- Carbapenem sparing: strategic use in resistant infections
Indications
- Lower Respiratory Tract Infections (LRTI)
- Complicated Skin and Soft Tissue Infections (cSSTI)
- Urinary Tract Infections (UTI)
- Acute Otitis Media
- Bacteremia
- Pelvic Inflammatory Disease
Dosage & Administration
- Form: Powder for solution for infusion
- Route: Intravenous (IV) use only
- Dosage: As directed by the physician
- Reconstitution: Use sterile water for injection
- Storage: Store below 25°C in a dry, dark place
